| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 47 |
| 1 | DARUNAVIR | 8 |
| 2 | DARUNAVIR 600 MG | 8 |
| 3 | DARUNAVIR 800 MG | 8 |
| 4 | RITONAVIR | 8 |
| 5 | ETONOGESTREL | 7 |
| 6 | RITONAVIR 100 MG | 6 |
| 7 | ADALIMUMAB | 4 |
| 8 | ETONOGESTREL AND ETHINYL ESTRADIOL | 4 |
| 9 | METHOTREXATE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROMOCRIPTINE MESYLATE | 1 | 0.0015 |
| 1 | DARUNAVIR 600 MG | 8 | 0.0013 |
| 2 | DARUNAVIR | 8 | 0.0005 |
| 3 | RITONAVIR 100 MG | 6 | 0.0004 |
| 4 | CODEINE SULFATE | 1 | 0.0003 |
| 5 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 1 | 0.0003 |
| 6 | LEVONORGESTREL | 47 | 0.0002 |
| 7 | MISOPROSTOL | 2 | 0.0002 |
| 8 | ETONOGESTREL AND ETHINYL ESTRADIOL | 4 | 0.0002 |
| 9 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin [EPC] | 58 | 0.0002 |
| 1 | Protease Inhibitor [EPC] | 8 | 0.0002 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 6 | Purine Antimetabolite [EPC] | 3 | 0.0000 |
| 7 | Estrogen [EPC] | 4 | 0.0000 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Copper-containing Intrauterine Device [EPC] | 1 | 0.0000 |